TATX-21

N/A

Report date: 2024/01/02 16:24:48

Base Information

Drug NameTATX-21
Drug Alias NameTATX-21
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionActivin receptor-like kinase 1 agonists
TargetsActivin receptor-like kinase 1
Therapy Area/IndicationsDiabetic RetinopathyPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTalem Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesImmunoPrecise Antibodies Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic RetinopathyPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A